What was the share price used for Veracyte (VCYT) tax withholding on June 2, 2026?

The Form 4 reports a price of $47.80 per share for the 3,730 Veracyte common shares withheld. This price is used solely for reporting the value of the tax-withholding disposition tied to restricted stock unit vesting.

Veracyte (VCYT) CSMO has shares withheld for RSU tax obligations

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

VERACYTE, INC. Chief Scientific & Medical Officer Phillip G. Febbo reported a routine share disposition tied to equity compensation. On June 2, 2026, 3,730 shares of common stock were withheld at $47.80 per share to cover tax withholding obligations from vesting restricted stock units, and the company notes this does not represent a market sale. Following this tax withholding event, Febbo directly holds 149,797 shares of common stock.

Insider Trade Summary 10b5-1

1 transaction reported

Mixed 1 txn

Insider Febbo Phillip G.

Role Chief Scientific & Med Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	3,730	$47.80	$178K

Holdings After Transaction: Common Stock — 149,797 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Tax-withheld shares: 3,730 shares Reporting share price: $47.80 per share Shares held after transaction: 149,797 shares +1 more

4 metrics

Tax-withheld shares 3,730 shares Common Stock withheld for tax on RSU vesting on June 2, 2026

Reporting share price $47.80 per share Value used for tax-withholding disposition of 3,730 shares

Shares held after transaction 149,797 shares Direct common stock holdings after June 2, 2026 withholding

Tax-withholding transactions 1 transaction, 3,730 shares Aggregate tax withholding activity in this Form 4

Key Terms

restricted stock units, tax withholding obligations, Common Stock, tax-withholding disposition

4 terms

restricted stock units financial

"in connection with the vesting of certain restricted stock units on June 2, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting"

Common Stock financial

"Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/04/2026 - 09:38 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Febbo Phillip G.

(Last)

(First)

(Middle)

6000 SHORELINE COURT, SUITE 300

(Street)

SOUTH SAN FRANCISCO

CALIFORNIA

94080

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Scientific & Med Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/02/2026		F⁽¹⁾		3,730	D	$47.8	149,797	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale.

Remarks:

	/s/ Jonathan Wygant, as attorney-in-fact	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Veracyte (VCYT) report for Phillip G. Febbo?

Veracyte reported that Chief Scientific & Medical Officer Phillip G. Febbo had 3,730 common shares withheld on June 2, 2026. The shares covered tax obligations from vesting restricted stock units and were not sold in the open market.

Was the Veracyte (VCYT) Form 4 transaction an open-market sale?

No, the Form 4 states the 3,730 Veracyte common shares were withheld for tax obligations. The footnote clarifies this withholding related to restricted stock unit vesting and "does not represent a sale" into the market.

How many Veracyte (VCYT) shares does Phillip G. Febbo hold after this Form 4?

After the June 2, 2026 tax-withholding transaction, Phillip G. Febbo directly holds 149,797 shares of Veracyte common stock. This figure reflects his position following the withholding of 3,730 shares for equity award tax obligations.

What does the F transaction code mean in the Veracyte (VCYT) Form 4?

The F code indicates a tax-withholding disposition, where shares are delivered to satisfy tax or exercise obligations. In this Veracyte filing, 3,730 shares were withheld for taxes on vesting restricted stock units and were not sold in the market.